Publications in collaboration with researchers from Centro Nacional de Microbiología (22)

2019

  1. Antibody responses to chimeric peptides derived from parasite antigens in mice and other animal species

    Molecular Immunology, Vol. 106, pp. 1-11

  2. In-plate recapturing of a dual-tagged recombinant Fasciola antigen (FhLAP) by a monoclonal antibody (US9) prevents nonspecific binding in ELISA

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Comparison of recombinant cathepsins L1, L2, and L5 as ELISA targets for serodiagnosis of bovine and ovine fascioliasis

    Parasitology Research, Vol. 117, Núm. 5, pp. 1521-1534

2017

  1. Delineating distinct heme-scavenging and -binding functions of domains in MF6p/helminth defense molecule (HDM) proteins from parasitic flatworms

    Journal of Biological Chemistry, Vol. 292, Núm. 21, pp. 8667-8682

  2. Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins

    PLoS ONE, Vol. 12, Núm. 11

2015

  1. ANISERP: A new serpin from the parasite Anisakis simplex

    Parasites and Vectors, Vol. 8, Núm. 1

2014

  1. The MF6p/FhHDM-1 major antigen secreted by the trematode parasite fasciola hepatica is a heme-binding protein

    Journal of Biological Chemistry, Vol. 289, Núm. 3, pp. 1441-1456

2012

  1. Ani s 1 and Ani s 7 recombinant allergens are able to differentiate distinct Anisakis simplex-associated allergic clinical disorders

    Archives of Dermatological Research, Vol. 304, Núm. 4, pp. 283-288

2011

  1. Development and evaluation of a new lateral flow immunoassay for serodiagnosis of human fasciolosis

    PLoS Neglected Tropical Diseases, Vol. 5, Núm. 11

  2. MISS-Prot: Web server for self/non-self discrimination of protein residue networks in parasites; Theory and experiments in Fasciola peptides and Anisakis allergens

    Molecular BioSystems, Vol. 7, Núm. 6, pp. 1938-1955

  3. Molecular and immunological characterization of Fasciola antigens recognized by the MM3 monoclonal antibody

    Molecular and Biochemical Parasitology, Vol. 179, Núm. 2, pp. 80-90

  4. Using entropy of drug and protein graphs to predict FDA drug-target network: Theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 4, pp. 1074-1094

2010

  1. Diagnosing human anisakiasis: Recombinant Ani s 1 and Ani s 7 allergens versus the UniCAP 100 fluorescence enzyme immunoassay

    Clinical and Vaccine Immunology, Vol. 17, Núm. 4, pp. 496-502

2009

  1. The Anisakis simplex Ani s 7 major allergen as an indicator of true Anisakis infections

    Clinical and Experimental Immunology, Vol. 156, Núm. 3, pp. 471-478

2008

  1. Mesa redonda 8: Distintas aproximaciones al diagnóstico de las enfermedades parasitarias

    Enfermedades Emergentes

  2. Mixed infection, Trichinella spiralis and Trichinella britovi, in a wild boar hunted in the Province of Cáceres (Spain)

    Experimental Parasitology, Vol. 119, Núm. 3, pp. 430-432

  3. Novel sequences and epitopes of diagnostic value derived from the Anisakis simplex Ani s 7 major allergen

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 63, Núm. 2, pp. 219-225

2006

  1. A recombinant enolase from Anisakis simplex is differentially recognized in natural human and mouse experimental infections

    Medical Microbiology and Immunology, Vol. 195, Núm. 1, pp. 1-10

2004

  1. Aplicación de la técnica PCR-RFLP en la identificación de nematodos implicados en la anisakiasis, humana

    Medicina Clinica, Vol. 122, Núm. 18, pp. 686-689

  2. Evaluation of Trichinella spiralis larva group 1 antigens for serodiagnosis of human trichinellosis

    Journal of Clinical Microbiology, Vol. 42, Núm. 9, pp. 4060-4066